-
Sector Analysis
NewEgypt Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Egypt Defense Market Report Overview In 2024, Egypt's defense budget is worth $5.2 billion, inclusive of US military aid. The country’s defense budget will grow at a CAGR of more than 3% during 2025-2029. Egypt’s increasing military expenditure is reflected in an ongoing modernization effort to counter terrorism in the Sinai Peninsula, strained relations with Ethiopia, political turmoil following the democratic revolution, and maritime security concerns over the Suez Canal. Furthermore, the country’s strained relations with Ethiopia over the construction...
-
Sector Analysis
Portugal Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Portugal Construction Market Report Overview The Portugal construction market size was $31.6 billion in 2023. The market will achieve an AAGR of more than 1% during 2025-2028. The growth is attributed to the increase in investments in transport and renewable energy infrastructure, with improvements in the electric vehicle market. Portugal Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the Portugal Construction Market Forecast Download a Free Report Sample The Portugal construction market research report...
-
Product Insights
Allergic Rhinitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Rhinitis - Drugs In Development, 2023’, provides an overview of the Allergic Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Androgenic Alopecia – Drugs In Development, 2023
Global Markets Direct’s, ‘Androgenic Alopecia - Drugs In Development, 2023’, provides an overview of the Androgenic Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Androgenic Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Alopecia – Drugs In Development, 2023
Global Markets Direct’s, ‘Alopecia - Drugs In Development, 2023’, provides an overview of the Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Ventos de Sao Januario 20
Ventos de Sao Januario 20 is an Onshore Wind project located in Bahia, Brazil. The project is owned by Salus Fundo de Investimento em Participacoes Mult; Ventos de Sao Januario Energias Renovaveis SA and was developed by Casa dos Ventos Energias Renovaveis SA; Salus Fundo de Investimento em Participacoes Mult; Ventos de Sao Januario Energias Renovaveis SA. The project came online in 2020. Empower your strategies with our Ventos de Sao Januario 20 report and make more profitable business decisions....
-
Product Insights
Ventos de Sao Januario 21
Ventos de Sao Januario 21 is an Onshore Wind project located in Bahia, Brazil. The project is owned by Salus Fundo de Investimento em Participacoes Mult; Ventos de Sao Januario Energias Renovaveis SA and was developed by Casa dos Ventos Energias Renovaveis SA; Salus Fundo de Investimento em Participacoes Mult; Ventos de Sao Januario Energias Renovaveis SA. The project came online in 2020. Empower your strategies with our Ventos de Sao Januario 21 report and make more profitable business decisions....
-
Product Insights
Ventos de Sao Januario 22
Ventos de Sao Januario 22 is an Onshore Wind project located in Bahia, Brazil. The project is owned by Salus Fundo de Investimento em Participacoes Mult; Ventos de Sao Januario Energias Renovaveis SA and was developed by Casa dos Ventos Energias Renovaveis SA; Salus Fundo de Investimento em Participacoes Mult; Ventos de Sao Januario Energias Renovaveis SA. The project came online in 2020. Empower your strategies with our Ventos de Sao Januario 22 report and make more profitable business decisions....
-
Track & Monitor
Innovation in consumer: Plant based antioxidants
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the consumer industry’s Plant based antioxidants segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Company Profile
EMS SA – Company Profile
EMS SA (EMS), a subsidiary of Grupo NC, is a pharmaceutical company that focuses on the development of products for the improvement of the health and well-being of the population. The company operates in the segments of medical prescription, generics, branded pharmaceuticals, manufacturing products, OTC, and hospitals. Its major product portfolio includes drugs in the therapeutic areas of anti-inflammatories, analgesics, antihypertensives, anthelmintics, antidiabetics, antibiotics, anti-ulcers, topical corticosteroids, and anti-flu. EMS has production units in Sao Bernardo do Campo, Jaguariuna and...
Add to Basket